Blanco-Prieto MJ - Search Results

1

Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.

Garbayo E, Ansorena E, Lanciego JL, Blanco-Prieto MJ, Aymerich MS. Garbayo E, et al. Mov Disord. 2011 Aug 15;26(10):1943-7. doi: 10.1002/mds.23793. Epub 2011 Jun 9. Mov Disord. 2011. PMID: 21661048

2

[Neuroprotective and neurorestorative therapies for the treatment of Parkinson's disease].

Garbayo E, Aymerich MS, Ansorena E, Lanciego JL, Blanco-Prieto MJ. Garbayo E, et al. An Sist Sanit Navar. 2006 Sep-Dec;29(3):325-35. doi: 10.4321/s1137-66272006000500002. An Sist Sanit Navar. 2006. PMID: 17224935 Free article. Review. Spanish.

3

Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor.

Garbayo E, Ansorena E, Lanciego JL, Aymerich MS, Blanco-Prieto MJ. Garbayo E, et al. Int J Pharm. 2007 Nov 1;344(1-2):9-15. doi: 10.1016/j.ijpharm.2007.04.003. Epub 2007 Apr 6. Int J Pharm. 2007. PMID: 17499462 Free article.

4

Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.

Garbayo E, Ansorena E, Lanciego JL, Aymerich MS, Blanco-Prieto MJ. Garbayo E, et al. Eur J Pharm Biopharm. 2008 Aug;69(3):844-51. doi: 10.1016/j.ejpb.2008.02.015. Epub 2008 Feb 23. Eur J Pharm Biopharm. 2008. PMID: 18417331 Free article.

5

Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

Garbayo E, Montero-Menei CN, Ansorena E, Lanciego JL, Aymerich MS, Blanco-Prieto MJ. Garbayo E, et al. J Control Release. 2009 Apr 17;135(2):119-26. doi: 10.1016/j.jconrel.2008.12.010. Epub 2008 Dec 25. J Control Release. 2009. PMID: 19154763 Free article.

6

Production of highly pure human glycosylated GDNF in a mammalian cell line.

Ansorena E, Garbayo E, Lanciego JL, Aymerich MS, Blanco-Prieto MJ. Ansorena E, et al. Int J Pharm. 2010 Jan 29;385(1-2):6-11. doi: 10.1016/j.ijpharm.2009.10.015. Epub 2009 Oct 13. Int J Pharm. 2010. PMID: 19825405 Free article.

7

Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.

Formiga FR, Pelacho B, Garbayo E, Abizanda G, Gavira JJ, Simon-Yarza T, Mazo M, Tamayo E, Jauquicoa C, Ortiz-de-Solorzano C, Prósper F, Blanco-Prieto MJ. Formiga FR, et al. J Control Release. 2010 Oct 1;147(1):30-7. doi: 10.1016/j.jconrel.2010.07.097. Epub 2010 Jul 17. J Control Release. 2010. PMID: 20643169 Free article.

8

A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system.

Ansorena E, Casales E, Aranda A, Tamayo E, Garbayo E, Smerdou C, Blanco-Prieto MJ, Aymerich MS. Ansorena E, et al. Int J Pharm. 2013 Jan 2;440(1):19-26. doi: 10.1016/j.ijpharm.2012.04.071. Epub 2012 May 1. Int J Pharm. 2013. PMID: 22580212 Free article.

9

Brain drug delivery systems for neurodegenerative disorders.

Garbayo E, Ansorena E, Blanco-Prieto MJ. Garbayo E, et al. Curr Pharm Biotechnol. 2012 Sep;13(12):2388-402. doi: 10.2174/138920112803341761. Curr Pharm Biotechnol. 2012. PMID: 23016644 Review.

10

Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia.

Formiga FR, Garbayo E, Díaz-Herráez P, Abizanda G, Simón-Yarza T, Tamayo E, Prósper F, Blanco-Prieto MJ. Formiga FR, et al. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):665-72. doi: 10.1016/j.ejpb.2013.02.017. Epub 2013 Mar 21. Eur J Pharm Biopharm. 2013. PMID: 23523545 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page